Systems modelling of the EGFR-PYK2-c-Met interaction network predicts and prioritizes synergistic drug combinations for triple-negative breast cancer.
Sung-Young ShinAnna-Katharina MüllerNandini VermaSima LevLan K. NguyenPublished in: PLoS Comput. Biol. (2018)